ETHINYL ESTRADIOL; NORETHINDRONE

Search structure


Trade Names:	ALYACEN 1/35 ALYACEN 7/7/7 ARANELLE BALZIVA-21 BALZIVA-28 BREVICON 21-DAY BREVICON 28-DAY BRIELLYN CYCLAFEM 0.5/35 CYCLAFEM 1/35 CYCLAFEM 7/7/7 CYONANZ DASETTA 1/35 DASETTA 7/7/7 FEMCON FE GENCEPT 10/11-21 GENCEPT 10/11-28 GILDAGIA KAITLIB FE MODICON 21 MODICON 28 N.E.E. 1/35 21 N.E.E. 1/35 28 NEXESTA FE NORCEPT-E 1/35 21 NORCEPT-E 1/35 28 NORETHIN 1/35E-21 NORETHIN 1/35E-28 NORETHINDRONE AND ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) NORETHINDRONE AND ETHINYL ESTRADIOL (7/14) NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE NORINYL 1+35 21-DAY NORINYL 1+35 28-DAY NORTREL 0.5/35-21 NORTREL 0.5/35-28 NORTREL 1/35-21 NORTREL 1/35-28 NORTREL 7/7/7 NYLIA 1/35 NYLIA 7/7/7 ORTHO-NOVUM 10/11-21 ORTHO-NOVUM 10/11-28 ORTHO-NOVUM 1/35-21 ORTHO-NOVUM 1/35-28 ORTHO-NOVUM 7/14-21 ORTHO-NOVUM 7/14-28 ORTHO-NOVUM 7/7/7-21 ORTHO-NOVUM 7/7/7-28 OVCON-35 OVCON-50 PHILITH PIRMELLA 1/35 PIRMELLA 7/7/7 TRI-NORINYL 21-DAY TRI-NORINYL 28-DAY VYFEMLA WERA
Status:	Approved
Entry Type:	Combination
Molecule Category:	Mixture
Compounds in the Mixture:	ETHINYL ESTRADIOL NORETHINDRONE

Related Entries

Parent

Parent

Adverse Reactions

SOC By Demographic Distribution

System Organ Classification (SOC)

	Relative Frequency (%)
General disorders and administration site conditions	19.35
Psychiatric disorders	17.29
Pregnancy, puerperium and perinatal conditions	7.79
Injury, poisoning and procedural complications	7.53
Social circumstances	6.46
Vascular disorders	6.21
Nervous system disorders	6.12
Reproductive system and breast disorders	5.22
Gastrointestinal disorders	5.11
Skin and subcutaneous tissue disorders	3.3
Respiratory, thoracic and mediastinal disorders	2.28

CONTENTS